Friso G J Calkoen

13PUBLICATIONS
84CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Adolescent healthNanotoxicology, health and safetyMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 21, 2026
Human CART22.19 therapy in refractory pediatric B-ALL: insights from a named-patient cohort.

|Nov 19, 2025
Outcomes of BCP-ALL with hypodiploidy or BCR::ABL1 fusion in children undergoing allogeneic HSCT: results from the FORUM study.

Jochen Buechner, Ulrike Poetschger, Peter Bader

|May 30, 2025
Phase 1/2 trial of anti-CD7 allogeneic WU-CART-007 for patients with relapsed/refractory T-cell malignancies.

Armin Ghobadi, Ibrahim Aldoss, Shannon L Maude

|May 15, 2025
CAR-T cell manufacturing failures and out-of-specification products in the real-world setting: A survey from the EBMT cellular therapy and immunobiology working party.

Nina Worel, Jarl E Mooyaart, Jorinde D Hoogenboom

|Mar 13, 2025
Unusual Partners: γδ-TCR-Based T Cell Therapy in Combination with Oncolytic Virus Treatment for Diffuse Midline Gliomas.

Konstantinos Vazaios, Patricia Hernández López, Tineke Aarts-Riemens

|Feb 21, 2025
Improved survival with model-based dosing of antithymocyte globulin in pediatric hematopoietic cell transplantation.

Rick Admiraal, Stefan Nierkens, Marc B Bierings

Pageof 3

Frequent Collaborators

2 joint publications

Stefan Nierkens

2 joint publications

Rafael de La Camara

2 joint publications

Pere Barba

2 joint publications

Pim Mutsaers